Breast cancer is the most common cancer among women worldwide. The term epidemiology generally deals with the branch of medicine and treatment that deals with a specific incident. Thus, considering the topic of breast cancer, this particular study deals with the distribution, determinants, and frequency of the disease. Breast cancer incidence and death data are critical to determining healthcare priorities. Women’s cancer is the most common, accounting for 25.1 percent of all malignancies. According to this specific report, more than 42,000 women die from breast cancer each year. Hence, it is apparent that it is the second leading cause of death among women, especially in the US. Family history/genetics, reproductive, hormone, benign proliferative breast disease, and mammographic density are the four main risk factors for breast cancer that can be meaningfully categorized. These elements are briefly discussed, and the risk estimators are provided. Numerous screening technologies have found breast cancer; some are linked to an increased risk of breast cancer, such as ultrasound techniques and MRI scanning. Breast cancer is more common in developed countries, while relative mortality is highest in developing countries. Women’s education is recommended for early detection and treatment in all nations. Health policymakers must prioritize plans to control and prevent this malignancy and increase awareness of risk factors and early detection in less developed countries.
References
[1]
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: ACancerJournalforClinicians, 74, 229-263. https://doi.org/10.3322/caac.21834
[2]
Xu, Y., Gong, M., Wang, Y., Yang, Y., Liu, S. and Zeng, Q. (2023) Global Trends and Forecasts of Breast Cancer Incidence and Deaths. ScientificData, 10, Article No. 334. https://doi.org/10.1038/s41597-023-02253-5
[3]
Ghoncheh, M., Pournamdar, Z. and Salehiniya, H. (2016) Incidence and Mortality and Epidemiology of Breast Cancer in the World. AsianPacificJournalofCancerPrevention, 17, 43-46. https://doi.org/10.7314/apjcp.2016.17.s3.43
[4]
Sun, Y., Zhao, Z., Yang, Z., Xu, F., Lu, H., Zhu, Z., et al. (2017) Risk Factors and Preventions of Breast Cancer. InternationalJournalofBiologicalSciences, 13, 1387-1397. https://doi.org/10.7150/ijbs.21635
[5]
Sedeta, E.T., Jobre, B. and Avezbakiyev, B. (2023) Breast Cancer: Global Patterns of Incidence, Mortality, and Trends. JournalofClinicalOncology, 41, 10528-10528. https://doi.org/10.1200/jco.2023.41.16_suppl.10528
[6]
Milosevic, M., Jankovic, D., Milenkovic, A. and Stojanov, D. (2018) Early Diagnosis and Detection of Breast Cancer. TechnologyandHealthCare, 26, 729-759. https://doi.org/10.3233/thc-181277
[7]
Lashof, J.C., Henderson, I.C. and Nass, S.J. (2001) Mammography and Beyond: Developing Technologies for the Early Detection of Breast Cancer. National Academies Press.
[8]
US Preventive Services Task Force (2024) Screening for Breast Cancer. JAMA, 331, 1973-1974. https://doi.org/10.1001/jama.2024.5535
[9]
Glechner, A., Wagner, G., Mitus, J.W., Teufer, B., Klerings, I., Böck, N., et al. (2023) Mammography in Combination with Breast Ultrasonography versus Mammography for Breast Cancer Screening in Women at Average Risk. CochraneDatabaseofSystematicReviews, No. 3, CD009632. https://doi.org/10.1002/14651858.cd009632.pub3
[10]
Ginsburg, O., Yip, C., Brooks, A., Cabanes, A., Caleffi, M., Dunstan Yataco, J.A., et al. (2020) Breast Cancer Early Detection: A Phased Approach to Implementation. Cancer, 126, 2379-2393. https://doi.org/10.1002/cncr.32887
[11]
Pashayan, N., Antoniou, A.C., Ivanus, U., Esserman, L.J., Easton, D.F., French, D., et al. (2020) Personalized Early Detection and Prevention of Breast Cancer: ENVISION Consensus Statement. NatureReviewsClinicalOncology, 17, 687-705. https://doi.org/10.1038/s41571-020-0388-9
[12]
Wheeler, S.B., Rocque, G. and Basch, E. (2024) Benefits of Breast Cancer Screening and Treatment on Mortality. JAMA, 331, 199-200. https://doi.org/10.1001/jama.2023.26730
[13]
Alshawwa, I.A., El-Mashharawi, H.Q., Salman, F.M., Al-Qumboz, M.N.A., Abu-Nasser, B.S. and Abu-Naser, S.S. (2024) Advancements in Early Detection of Breast Cancer: Innovations and Future Directions. International Journal of Academic Engineering Research, 8, 17-25.
[14]
Manrique-Moreno, M., Santa-González, G.A. and Gallego, V. (2021) Bioactive Cationic Peptides as Potential Agents for Breast Cancer Treatment. BioscienceReports, 41, BSR20211218C. https://doi.org/10.1042/bsr20211218c
[15]
Hester, R.H., Hortobagyi, G.N. and Lim, B. (2021) Inflammatory Breast Cancer: Early Recognition and Diagnosis Is Critical. AmericanJournalofObstetricsandGynecology, 225, 392-396. https://doi.org/10.1016/j.ajog.2021.04.217
[16]
MU, N., Jafran, S.S. and Paul, A. (2024) Inflammatory Breast Cancer: Challenges and Opportunities in the Management. SaudiJournalofMedicine, 9, 146-153. https://doi.org/10.36348/sjm.2024.v09i05.007
[17]
Ahmed, N. (2023) Breast Pain. InnovAiT: EducationandInspirationforGeneralPractice, 16, 327-331. https://doi.org/10.1177/17557380231168654
[18]
Shen, A., Zhang, Z., Ye, J., Wang, Y., Zhao, H., Li, X., et al. (2024) Arm Symptom Pattern among Breast Cancer Survivors with and without Lymphedema: A Contemporaneous Network Analysis. TheOncologist, 29, e1656-e1668. https://doi.org/10.1093/oncolo/oyae217
[19]
Zengin, H.B., Tan, P.H., Liu, R. and Smoller, B.R. (2024) ‘Eczematous’ Dermatitis of the Nipple: Clinical and Histopathological Differential Diagnosis of Paget Disease. Pathology, 56, 300-312. https://doi.org/10.1016/j.pathol.2023.10.018
[20]
Morozova, A., Cotes, C., Aran, S. and Singh, H. (2023) Challenges in Interpretation of US Breast Findings in the Emergency Setting. RadioGraphics, 43, e230020. https://doi.org/10.1148/rg.230020
[21]
Abd Alkareem, T., Hassan, S. and Abdalhadi, S. (2023) Breast Cancer: Symptoms, Causes, and Treatment by Metal Complexes: A Review. Advanced Journal of Chemistry-Section B: Natural Products and Medical Chemistry, 5, 306-319.
[22]
Zaylaa, A.J. and Kourtian, S. (2024) Advancing Breast Cancer Diagnosis through Breast Mass Images, Machine Learning, and Regression Models. Sensors, 24, Article 2312. https://doi.org/10.3390/s24072312
[23]
Satpathi, S., Gaurkar, S.S., Potdukhe, A. and Wanjari, M.B. (2023) Unveiling the Role of Hormonal Imbalance in Breast Cancer Development: A Comprehensive Review. Cureus, 15, e41737. https://doi.org/10.7759/cureus.41737
[24]
Wan, A., Zhang, G., Ma, D., Zhang, Y. and Qi, X. (2023) An Overview of the Research Progress of BRCA Gene Mutations in Breast Cancer. BiochimicaetBiophysicaActa (BBA)—ReviewsonCancer, 1878, Article ID: 188907. https://doi.org/10.1016/j.bbcan.2023.188907
[25]
Coughlin, S.S. (2019) Epidemiology of Breast Cancer in Women. In: Ahmad, A., Ed., Breast Cancer Metastasis and Drug Resistance, Springer International Publishing, 9-29. https://doi.org/10.1007/978-3-030-20301-6_2
[26]
Tao, Z., Shi, A., Lu, C., Song, T., Zhang, Z. and Zhao, J. (2014) Breast Cancer: Epidemiology and Etiology. CellBiochemistryandBiophysics, 72, 333-338. https://doi.org/10.1007/s12013-014-0459-6
[27]
Miziak, P., Baran, M., Błaszczak, E., Przybyszewska-Podstawka, A., Kałafut, J., Smok-Kalwat, J., et al. (2023) Estrogen Receptor Signaling in Breast Cancer. Cancers, 15, Article 4689. https://doi.org/10.3390/cancers15194689
[28]
Check, J.H. and Check, D.L. (2023) The Role of Progesterone and the Progesterone Receptor in Cancer: Progress in the Last 5 Years. ExpertReviewofEndocrinology&Metabolism, 18, 5-18. https://doi.org/10.1080/17446651.2023.2166487
[29]
Obeagu, E.I. and Obeagu, G.U. (2024) Breast Cancer: A Review of Risk Factors and Diagnosis. Medicine, 103, e36905. https://doi.org/10.1097/md.0000000000036905
[30]
Badar, F., Mahmood, S., Faraz, R., Yousaf, A., Quader, A.U. and Asif, H. (2015) Epidemiology of Breast Cancer at the Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan. Journal of College of Physicians and Surgeons Pakistan, 25, 738-742.
[31]
Rojas, K. and Stuckey, A. (2016) Breast Cancer Epidemiology and Risk Factors. ClinicalObstetrics&Gynecology, 59, 651-672. https://doi.org/10.1097/grf.0000000000000239
[32]
Balekouzou, A., Yin, P., Pamatika, C.M., Bishwajit, G., Nambei, S.W., Djeintote, M., et al. (2016) Epidemiology of Breast Cancer: Retrospective Study in the Central African Republic. BMCPublicHealth, 16, Article No. 1230. https://doi.org/10.1186/s12889-016-3863-6
[33]
Lee, C.I., Chen, L.E. and Elmore, J.G. (2017) Risk-Based Breast Cancer Screening. MedicalClinicsofNorthAmerica, 101, 725-741. https://doi.org/10.1016/j.mcna.2017.03.005
[34]
da Costa Vieira, R.A., Biller, G., Uemura, G., Ruiz, C.A. and Curado, M.P. (2017) Breast Cancer Screening in Developing Countries. Clinics, 72, 244-253. https://doi.org/10.6061/clinics/2017(04)09
[35]
Iranmakani, S., Mortezazadeh, T., Sajadian, F. et al. (2020) A Review of Various Modalities in Breast Imaging: Technical Aspects and Clinical Outcomes. Egyptian Journal of Radiology and Nuclear Medicine, 51, 1-22. https://doi.org/10.1186/s43055-020-00175-5
[36]
Doyle, A., O’Dwyer, C., Mongan, D., Millar, S.R. and Galvin, B. (2023) Factors Associated with Public Awareness of the Relationship between Alcohol Use and Breast Cancer Risk. BMCPublicHealth, 23, Article No. 577. https://doi.org/10.1186/s12889-023-15455-8
[37]
Wang, L. (2017) Early Diagnosis of Breast Cancer. Sensors, 17, Article 1572. https://doi.org/10.3390/s17071572
[38]
Habib, O.S., Hameed, L.A., Ajeel, N.A., Al-Hawaz, M.H., Al-Faddagh, Z.A., Nasr, G.N., et al. (2016) Epidemiology of Breast Cancer among Females in Basrah. AsianPacificJournalofCancerPrevention, 17, 191-195. https://doi.org/10.7314/apjcp.2016.17.s3.191
[39]
Alagoz, O., Ergun, M.A., Cevik, M., Sprague, B.L., Fryback, D.G., Gangnon, R.E., et al. (2018) The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update. MedicalDecisionMaking, 38, 99S-111S. https://doi.org/10.1177/0272989x17711927
[40]
Zavala, V.A., Serrano-Gomez, S.J., Dutil, J. and Fejerman, L. (2019) Genetic Epidemiology of Breast Cancer in Latin America. Genes, 10, Article 153. https://doi.org/10.3390/genes10020153
[41]
Stapleton, S.M., Oseni, T.O., Bababekov, Y.J., Hung, Y. and Chang, D.C. (2018) Race/ethnicity and Age Distribution of Breast Cancer Diagnosis in the United States. JAMASurgery, 153, 594-595. https://doi.org/10.1001/jamasurg.2018.0035
[42]
Doren, E.L., Miranda, R.N., Selber, J.C., Garvey, P.B., Liu, J., Medeiros, L.J., et al. (2017) U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plastic&ReconstructiveSurgery, 139, 1042-1050. https://doi.org/10.1097/prs.0000000000003282
[43]
Ferzoco, R.M. and Ruddy, K.J. (2015) The Epidemiology of Male Breast Cancer. CurrentOncologyReports, 18, Article No. 1. https://doi.org/10.1007/s11912-015-0487-4
[44]
Williams, L.J., Fletcher, E., Douglas, A., Anderson, E.D.C., McCallum, A., Simpson, C.R., et al. (2017) Retrospective Cohort Study of Breast Cancer Incidence, Health Service Use and Outcomes in Europe: A Study of Feasibility. EuropeanJournalofPublicHealth, 28, 327-332. https://doi.org/10.1093/eurpub/ckx127
[45]
McCormack, V., McKenzie, F., Foerster, M., Zietsman, A., Galukande, M., Adisa, C., et al. (2020) Breast Cancer Survival and Survival Gap Apportionment in Sub-Saharan Africa (ABC-DO): A Prospective Cohort Study. TheLancetGlobalHealth, 8, e1203-e1212. https://doi.org/10.1016/s2214-109x(20)30261-8
[46]
Reinert, T. and Barrios, C.H. (2015) Optimal Management of Hormone Receptor Positive Metastatic Breast Cancer in 2016. TherapeuticAdvancesinMedicalOncology, 7, 304-320. https://doi.org/10.1177/1758834015608993
[47]
Sledge, G.W., Mamounas, E.P., Hortobagyi, G.N., Burstein, H.J., Goodwin, P.J. and Wolff, A.C. (2014) Past, Present, and Future Challenges in Breast Cancer Treatment. JournalofClinicalOncology, 32, 1979-1986. https://doi.org/10.1200/jco.2014.55.4139
[48]
Wuerstlein, R. and Harbeck, N. (2017) Neoadjuvant Therapy for HER2-Positive Breast Cancer. ReviewsonRecentClinicalTrials, 12, 81-92. https://doi.org/10.2174/1574887112666170202165049
[49]
Tong, C.W.S., Wu, M., Cho, W.C.S. and To, K.K.W. (2018) Recent Advances in the Treatment of Breast Cancer. FrontiersinOncology, 8, Article 227. https://doi.org/10.3389/fonc.2018.00227
[50]
Eccles, S.A., Aboagye, E.O., Ali, S., Anderson, A.S., Armes, J., Berditchevski, F., et al. (2013) Critical Research Gaps and Translational Priorities for the Successful Prevention and Treatment of Breast Cancer. BreastCancerResearch, 15, Article No. R92. https://doi.org/10.1186/bcr3493
[51]
Howell, A., Anderson, A.S., Clarke, R.B., Duffy, S.W., Evans, D.G., Garcia-Closas, M., et al. (2014) Risk Determination and Prevention of Breast Cancer. BreastCancerResearch, 16, Article No. 446. https://doi.org/10.1186/s13058-014-0446-2
[52]
Zhang, S.M., Hankinson, S.E., Hunter, D.J., Giovannucci, E.L., Colditz, G.A. and Willett, W.C. (2005) Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status. CancerEpidemiology, Biomarkers&Prevention, 14, 2004-2008. https://doi.org/10.1158/1055-9965.epi-05-0083
[53]
Colditz, G.A. and Bohlke, K. (2014) Priorities for the Primary Prevention of Breast Cancer. CA: ACancerJournalforClinicians, 64, 186-194. https://doi.org/10.3322/caac.21225
